Navigation Links
Revise guidelines for weight gain during pregnancy, says Saint Louis U. obstetrician
Date:3/11/2008

ST. LOUIS -- Current recommendations for weight gain during pregnancy developed by the Institute of Medicine (IOM) in 1990 should be revised, according to an internationally recognized obesity expert and chairman of the department of obstetrics, gynecology and womens health at Saint Louis University.

The editorial by Raul Artal, M.D., who has conducted extensive research on obesity during pregnancy, appears in the March issue of Expert Review of Obstetrics and Gynecology, an international medical journal.

Recommendations by the IOM, which are followed worldwide by obstetricians, encourage obese women to gain at least 15 pounds during pregnancy and specify no upper limit for weight gain. The IOM is a panel of national experts who provide advice on medical and health issues.

Overweight or obese women dont need to gain that much weight and should exercise and watch their calorie consumption during pregnancy, Artal said.

Pregnancy has become over the years a state of indulgence and confinement, he wrote. Pregnancy is an ideal time for behavior modification that includes physical activity and with proper medical supervision it can be safely prescribed.

The IOM guidelines were not grounded in scientific evidence, Artal said, and focused primarily on preventing low birth-weight deliveries, which generally occur when women who are underweight and of normal weight dont gain enough weight during pregnancy.

He added the guidelines did not take into account the other factors that could restrict the growth of babies. Nor did they consider the impact of excessive weight gain on the health of the fetus and mother, he wrote.

There is still a prevailing reluctance among health care providers to prescribe lifestyle modification in pregnancy that includes judicious diet and exercise, Artal said. The perception is that pregnancy is not an opportune time for such interventions because of potential risk to the fetus.

If overweight pregnant women control the number of calories they consume and maintain a physically active lifestyle, they can fight problems that commonly come from obesity, such as hypertension and diabetes, he wrote.

Artal recommended that in uncomplicated pregnancies, all women, even those who are obese, should engage in physical activity.

Previous studies have demonstrated that engaging in exercise activities in pregnancy is safe, he wrote. Obese women should not be precluded from engaging in physical activities. Obese pregnant women who engage in physical activities during their pregnancies reduce their risk of developing gestational diabetes by 50 percent.

In addition, obese women should limit the amount of weight they gain during pregnancy by eating only enough to provide adequate calories and nourishment for their growing babies.

Artal blamed the obesity epidemic in part on excessive weight gain during pregnancy.

We can certainly speculate that for overweight and obese pregnant women who gained at least 15 pounds during their pregnancies (and evidence suggests that they gain more), pregnancy has become a major contributing factor to the epidemic of obesity, since the general tendency is to retain the weight post-partum.

He urged overweight women who are pregnant to exercise and change their eating habits, which would have a trickle-down effect on the health of the entire family as everyone is likely to eat healthier.

Pregnancy is the time when women are motivated to make changes to improve their lifestyle. It is an optimal time for health care providers to offer their support through community resources to decrease maternal obesity thus impacting the lives of future generations, Artal wrote.


'/>"/>

Contact: Nancy Solomon
solomonn@slu.edu
314-977-8017
Saint Louis University
Source:Eurekalert

Related medicine news :

1. WellPoint Revises 2008 Earnings Per Share Guidance
2. HRSA Proposes Rule to Revise, Combine HPSAs, MUPs
3. Mylan Revises Timing of Its Financial Results Conference Call for the Quarter and Nine Months Ended Dec. 31, 2007, to 5 p.m. ET
4. Cardinal Health Reports Second Quarter Results, Revises EPS Outlook
5. Schedules Revised for Flu, Meningitis Vaccines
6. Centocor, Schering-Plough Revise Agreement Covering REMICADE, Golimumab
7. GSK Revises US Labeling for Avandia(R)
8. Chest Compressions Key to Revised CPR Guidelines
9. Revised California Stem Cell Research Rules Fail to Ensure Affordable Access to Cures, Consumers Warn
10. Isis Favorably Revises Financial Guidance and Introduces Mipomersen as Generic Name for ISIS 301012
11. NUCRYST and Smith & Nephew Revise Agreements
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... ... , ... "I have gout, and I wanted to treat it naturally," said ... to relieve gout and pain caused by varicose veins. I drank it every morning ... relieved what VA doctors called the worst sinusitis case they'd seen and relieved gas, ...
(Date:12/9/2016)... ... December 09, 2016 , ... The Holy Name Medical Center ... NY, on December 3rd, to benefit Holy Name Medical Center's programs and services. ... raised over $1 million - the largest event in the Center's history, both ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... by the Undersea and Hyperbaric Medical Society (UHMS), the leading authority in hyperbaric ... patient safety. Only a few hospitals and facilities have earned this distinction. This ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... Therapy Management (MTM), adherence, and other pharmacist-delivered patient care services, has announced the ... and Eric Hoessel to vice president of sales. , Litsinger joined Mirixa ...
(Date:12/8/2016)... ... 08, 2016 , ... SunView Software aims to redefine IT ... both engaging and easy to use. Coming off the heels of a successful ... its plans to roll out new AI-powered self-service enhancements to help organizations implement ...
Breaking Medicine News(10 mins):
(Date:12/9/2016)... 9, 2016 Research and Markets has ... report to their offering. ... The report forecasts the global optical transceiver market ... The report covers the present scenario and the ... calculate the market size, the report considers the revenue generated from ...
(Date:12/9/2016)... aTyr Pharma, Inc. (Nasdaq: LIFE ), a biotherapeutics company ... severe, rare diseases, today announced that senior management will participate in ... Conference at the InterContinental Barclay Hotel in New York ... ET. About aTyr Pharma ... aTyr Pharma is engaged in the ...
(Date:12/9/2016)... Bermuda , Dec. 9, 2016  Axovant ... leading clinical-stage biopharmaceutical company focused on the treatment ... the data from a Phase 2b trial evaluating ... care donepezil, compared with donepezil plus placebo in ... that the addition of intepirdine to treatment was ...
Breaking Medicine Technology: